Ophthalmic formulation for treating myopia comprising dopamine a

Details Ophthalmic formulation for treating myopia comprising dopamine a Ophthalmic formulation for treating myopia comprising dopamine a

1996-10-02

1998-09-29

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514912, A61K 31495

Patent

active

058146385

ABSTRACT:
An ophthalmic formulation for treating myopia, which comprises a dopamine agonist and cyclodextrin or its derivative in combination with a pharmaceutically acceptable carrier.

REFERENCES:
patent: 4727064 (1988-02-01), Pitha
WPIDS 003105 (1989)--Iuvone et al.
WPID33500 (1984).
T. Loftsson et al., PZ Wiss., vol. 136, No. 1, pp. 5-10 (1991).
J. Szejtli, Pharm. Tech. Int., vol. 3, No. 2, pp. 15-22 (1991).
O. Reer et al., J. Pharm. Sci., vol. 83, No. 9, pp. 1345-1349 (1994).
K. A. Freedman et al., Curr. Eye. Res., vol. 12, No. 7, pp. 641-647 (1993).

Affiliated with

Also associated with

Rating

Ophthalmic formulation for treating myopia comprising dopamine a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic formulation for treating myopia comprising dopamine a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic formulation for treating myopia comprising dopamine a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-686573